《Table 1Characteristics of the studies included in the meta-analysis.》

《Table 1Characteristics of the studies included in the meta-analysis.》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Protein induced by vitamin K absence or antagonist-Ⅱ versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
Mixed:the etiology including HBV infection，HCV infection，alcohol and other；AFP:alpha-fetoprotein；NA:not available；PIVKA-II:protein induced by vitamin Kabsence or antagonist-II.*:The controls are malignant disease group，benign diseases group，chronic liv

Of the 2567 potentially relevant papers，45 were eligible for inclusion in this study according to their titles and abstracts.After reading the full texts，14 more papers were excluded.Thus，31studies were finally included in this meta-analysis.The process of study selection is described in Fig.1.The characteristics of all the included studies are presented in Table 1.

图表编号XD0020455700    严禁用于非法目的
绘制时间2018.12.15
作者Hao Xing、Yi-Jie Zheng、Jun Han、Han Zhang、Zhen-Li Li、Wan-Yee Lau、Feng Shen、Tian Yang
绘制单位Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University、Medical Scientific Affairs, Abbott Diagnostics、Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University、Department of He
更多格式高清、无水印（增值服务）

相关图表

  1. 《续表1 纳入研究的基本特征Continued table 1 Basic information included in the studies》2021.01.20
  2. 《Table 1 Summary of the main characteristics of the 4 studies included in the meta-analysis》2018.06.01
  3. 《Table 1 Demographics of patients with inflammatory bowel disease included in the studies》2019.07.28
  4. 《Table 1 Characteristics of the studies included in the meta-analysis》2019.05.21
  5. 《Table 2 Quality assessment of the included studies》2019.01.03
  6. 《Table 1 Characteristics of the included studies》2019.01.03
  7. 《Table 1 Characteristics of the included studies》2019.01.03
  8. 《Table.General characteristics of studies on DCAG regimen included in the Meta-analysis》2019.04.20
  9. 《Table 1 Key characteristics of the included studies》2019.03.18
  10. 《Table 2 Key characteristics of the included studies》2019.03.18
  11. 《表1 纳入文献基本特征Tab.1 Characteristics of the studies included in the Meta-analysis》2019.03.05
  12. 《Table 1.Main Characteristics of the Included Studies》2019.03.20
  13. 《Table 1 Basic information for the 28 studies included in the meta-analysis》2019.01.30
  14. 《Table 1 Basic information for the 28 studies included in the meta-analysis》2019.01.30
  15. 《Table 2 Preoperative clinical data of the eyes included in the study in both subgroups》2019.04.18
  16. 《Table 5 Genotype-Phenotype correlations of the patients included in the study》2019.04.18
  17. 《Table 1 The main characteristics of the included studies on DR》2019.02.18
  18. 《Table 1 The general characteristics of included studies》2019.02.18
  19. 《Table 1Characteristics of the 14 trials included in the meta-analysis.》2018.02.01
  20. 《Table 1Baseline characteristics of included patients in the study (n=18 948) .》2018.02.01

随机翻阅

《表1 两组患者临床疗效比较[例(%)]》 《表2 培土生金方的潜在核心靶点》 《表5 HRB400E不同工艺下轧制制度》 《表1 钢板化学成分(质量分数，%)》 《表2 两组患者治疗前后各项生化指标比较（±s)》 《表1 两组患者性别、年龄、病程的比较》 《表1 中国“十四五”时期的经济发展水平》 《表2 两组患儿雾化治疗的有效率比较[例 (%) ]》 《表1 田块技术路线对比情况》 《表1 原油及腐蚀管垢的化学成分Tab.1 Chemical composition of oil and corrosion scale》